GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Claritev Corp
Claritev, a health insurance company, is valued for its ability to analyze data to optimize costs. Its potential share price will reflect the effectiveness of its platform and the success of its contracts with major insurance and healthcare organizations.
Share prices of companies in the market segment - Medstrakh
Claritev's value as a company in the health insurance sector is determined by its ability to manage costs and attract customers. We classify it as a Medstrakh company, and the chart below reflects the dynamics of the entire industry, which is dependent on regulatory policy and competition.
Broad Market Index - GURU.Markets
Claritev is a company operating at the intersection of medicine and data, providing analytical solutions to optimize processes in health insurance. As part of the GURU.Markets index, it represents the Health-tech sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
CTEV - Daily change in the company's share price Claritev Corp
Change_co for Claritev, a health insurance company, reflects sensitivity to changes in healthcare policy. Daily fluctuations reflect the reaction to regulatory news. This metric is important for analyzing companies in the Medstrakh sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medstrakh
The health insurance sector, in which Claritev Corp operates, is highly dynamic. This chart reflects the average volatility of the industry. It serves as a benchmark for assessing Claritev's business's sensitivity to general trends, regulatory changes, and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Claritev is a healthcare insurance and technology company. The healthcare sector is subject to change, driven by demographics, insurance coverage, and regulation. The chart below shows the overall volatility of the industry, helping to assess the stability or volatility of Claritev's business.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Claritev Corp
Claritev is a technology-based insurance company. Its year-over-year performance reflects its ability to manage medical costs and compete with industry giants. The chart below tells the story of its performance in the complex and ever-changing US healthcare system.
Annual dynamics of market capitalization of the market segment - Medstrakh
Claritev, as a player in the health insurance market, likely uses technology to improve underwriting or administration. The success of such companies depends on their ability to demonstrate cost savings to insurers. Its performance relative to the sector will demonstrate how effective its technology model is compared to traditional approaches.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Claritev is privately held and not publicly traded on major exchanges. Its market performance cannot be analyzed. As its name suggests, its health insurance business is defensive, but its success is determined by its ability to effectively manage costs and compete in the challenging healthcare market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Claritev Corp
Claritev's performance as a health insurance company will be dependent on regulatory and operational cycles. Monthly fluctuations on the chart will reflect changes in the number of insured individuals, the medical loss ratio, and changes in government healthcare policy.
Monthly dynamics of market capitalization of the market segment - Medstrakh
The information services and analytics sector for science and business is a key element of the knowledge economy. Its market capitalization dynamics, shown in the chart, reflect the value of unique data. In this environment, companies like Clarivate provide critical information for decision-making.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Claritev likely operates in the health insurance or IT sectors. Shares of such companies can be relatively stable, as the healthcare sector is less susceptible to economic cycles. Their performance depends on industry reforms and contract signings.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Claritev Corp
Claritev, a provider of analytical IT solutions for the pharmaceutical industry, reacts weekly to sector news. Announcements of contracts with major drugmakers, as well as general trends in the use of data in R&D, shape short-term momentum.
Weekly dynamics of market capitalization of the market segment - Medstrakh
Claritev and the entire healthcare IT solutions sector are growing on the general trend of data use in healthcare. The pursuit of efficiency is a driving force for everyone. The chart below shows how the company competes for share in this promising market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Claritev, as a healthcare company, can demonstrate defensive properties. Demand for its IT services is unaffected by the state of the economy. The chart allows you to compare its performance with the S&P 500 and determine whether it is a safe haven.
Market capitalization of the company, segment and market as a whole
CTEV - Market capitalization of the company Claritev Corp
The ticker symbol CTEV (Clarivate) has been changed. If it were the old company, its chart would reflect the value of a business in the scientific and academic information sector. The current performance of any new CTEV ticker symbol is a history of investor expectations for the new business, whether in biotech or another industry where the market is trying to determine fair value from scratch.
CTEV - Share of the company's market capitalization Claritev Corp within the market segment - Medstrakh
Claritev Corp. is likely a company operating in the health insurance or related technologies sector. Its share of the sector will reflect its scale and innovation. The graph will show how relevant its solutions are to the complex and ever-changing US healthcare system.
Market capitalization of the market segment - Medstrakh
Claritev Corp operates in the health insurance industry. The chart below shows the total market capitalization of this vast and complex sector. Its dynamics reflect regulatory changes, medical costs, and efforts to make the system more efficient. Claritev is seeking its niche in this ecosystem.
Market capitalization of all companies included in a broad market index - GURU.Markets
Health insurance, as shown in the graph, requires complex IT solutions. Claritev Corp (formerly MultiPlan) provides data analysis and cost management services to insurance companies. Its market capitalization reflects its role in reducing costs in the US healthcare system.
Book value capitalization of the company, segment and market as a whole
CTEV - Book value capitalization of the company Claritev Corp
Claritev's (formerly AMN Healthcare) chart historically reflected the asset base of the leader in medical staffing. Its book value reflected the value of its network of offices and technology platforms that connect hospitals with nurses and doctors. This is the physical infrastructure for healthcare staffing.
CTEV - Share of the company's book capitalization Claritev Corp within the market segment - Medstrakh
Claritev Corp, formerly MultiPlan, is a provider of technology solutions to reduce healthcare costs. Its share of physical assets in the sector is small and consists of operational centers. Its strength lies in its data and analytics platforms, not physical infrastructure.
Market segment balance sheet capitalization - Medstrakh
Claritev Corp likely operates in the medical technology sector. The sector's asset chart indicates the industry's scale. If it's an IT company, it's asset-light. If it produces equipment, it's capital-intensive. Its model determines its asset structure.
Book value of all companies included in the broad market index - GURU.Markets
Claritev Corp, formerly T Stamp Inc., specializes in artificial intelligence-based digital identification solutions. Its book value reflects its patent portfolio and developed software solutions, rather than its physical assets.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Claritev Corp
Claritev Corp is a healthcare technology company. Its valuation represents a premium to its modest assets, reflecting investors' faith in the potential of its data analytics platform to improve the efficiency of health insurance.
Market to book capitalization ratio in a market segment - Medstrakh
Clarivate is a global company providing analytical information and data for science and business, owning databases such as the Web of Science. Its main assets are unique data and intellectual property. The chart shows how highly the market values ββthese intangible assets compared to their book value.
Market to book capitalization ratio for the market as a whole
Claritev Corp (likely a reference to Clarivate, CLVT) is an information analytics company that owns databases such as Web of Science. Compared to average market valuations, its valuation reflects the value of its unique content, but it is under pressure due to high debt and problems integrating past acquisitions.
Debts of the company, segment and market as a whole
CTEV - Company debts Claritev Corp
Claritev Corp., operating in the health insurance and technology sectors, likely uses capital to develop its software platforms and data analytics. Investments in IT and analytics are critical for optimizing insurance products and risk management. This chart may reflect how the company is funding its technological innovations to gain a competitive advantage.
Market segment debts - Medstrakh
Claritev Corp (formerly MultiPlan) provides cost management services to health insurers. Its business model is based on a technology platform. The company went public through a SPAC, resulting in significant debt on its balance sheet. This chart shows how the company is managing this debt load.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Claritev Corp
Claritev Corp is likely involved in healthcare insurance or related technologies. This chart shows its financial structure and leverage. In the healthcare sector, where regulatory changes can significantly impact business, maintaining a strong balance sheet is crucial. Debt levels help assess the financial risks a company faces.
Market segment debt to market segment book capitalization - Medstrakh
Clarivate (ticker symbol CTEV is incorrect, likely CLVT) is a global provider of analytics and data for scientific research and innovation. Its business model is based on subscriptions and the acquisition of unique databases. This chart shows the overall debt load in the sector. It helps understand how the company uses debt to finance M&A deals and develop its platforms.
Debt to book value of all companies in the market
Clarivate Plc (formerly Claritev) provides analytical data and information to academia and businesses. Its assets are primarily databases and intellectual property. Growth is often driven by acquisitions. This chart helps assess how actively Clarivate uses debt financing for its M&A strategy, relative to its overall capital availability.
P/E of the company, segment and market as a whole
P/E - Claritev Corp
This metric for Claritev Corp, a company operating in the healthcare IT and insurance sectors, reflects performance expectations. Such a company's P/E would be based on its ability to leverage technology to optimize processes in the conservative healthcare industry, which could lead to high growth and profitability.
P/E of the market segment - Medstrakh
Claritev Corp is a medical technology and insurance company. It develops platforms and solutions that help optimize healthcare processes and improve interactions between patients, doctors, and insurers. This chart shows the average rating for the sector, helping to understand how the market values ββClaritev's technology solutions.
P/E of the market as a whole
Clarivate (ticker CLVT, not CTEV) is a global provider of information and analytics for scientific research, patenting, and pharmaceuticals. Its business model is based on subscriptions for critical data, ensuring stable revenues less dependent on short-term economic cycles, as illustrated by this chart. Clarivate prioritizes R&D budgets.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Claritev Corp
Clarivate, formerly Clarivate Analytics, provides analytics and data for scientific research, pharmaceuticals, and intellectual property. Its revenue is subscription-based and stable. This chart shows how the market perceives the company's future revenue stability and growth from its subscription model, incorporating this into its profit forecasts.
Future (projected) P/E of the market segment - Medstrakh
Clarivate, formerly affiliated with Churchil Capital, is a global provider of analytics and data for scientific research, patents, and pharmaceuticals. This chart shows general expectations for the information services sector. CTEV's position relative to the average reflects the market's perception of the value of their data and their ability to integrate multiple acquisitions.
Future (projected) P/E of the market as a whole
Clarivate (previously Clarivate Analytics) provides data and analytics for scientific research and innovation. Its clients are universities and corporations whose R&D budgets are dependent on the overall economic situation. This growth expectation chart is a good indicator of future investment in science and innovation, which benefits Clarivate.
Profit of the company, segment and market as a whole
Company profit Claritev Corp
Clarivate (this company may have been the original name) provides analytical information and data for scientific research, pharmaceuticals, and intellectual property protection. Its revenue comes from subscriptions to databases and analytical tools, such as Web of Science, ensuring stable and predictable income.
Profit of companies in the market segment - Medstrakh
Clarivate provides analytical information and data for scientific research, pharmaceutical development, and intellectual property protection. Its clients include universities, R&D departments, and law firms. This chart shows the total revenue in the health insurance sector. It reflects the overall trends in healthcare digitalization and how technology helps optimize costs.
Overall market profit
Clarivate provides analytical information and data for scientific research and innovation. Its clients include universities, corporate R&D departments, and government agencies. When the economy is booming, as this chart shows, companies and governments increase spending on science and development. This directly drives demand for Clarivate's products, supporting its growth.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Claritev Corp
Claritev Corp (likely Clarivate Plc) provides analytical information and data for scientific research, pharmaceuticals, and intellectual property protection. Future revenue depends on subscriptions to its products. This chart reflects analyst expectations for growing demand for high-quality data and analytics in its key customer segments.
Future (predicted) profit of companies in the market segment - Medstrakh
Claritev Corp., serving the health insurance industry, provides analytical solutions and services to optimize costs and improve treatment outcomes. The company's success depends on the complexity of the healthcare system and the commitment of its stakeholders to efficiency. This chart reflects profitability forecasts for the entire sector, allowing one to assess how Claritev's technologies are responding to industry challenges.
Future (predicted) profit of the market as a whole
Clarivate (the ticker symbol has changed, but the essence remains) provides analytics and information services for science and business. Demand for its products is relatively stable, but depends on the R&D budgets of corporations and universities. This graph of corporate profits may indicate companies' willingness to invest in innovation and analytics.
P/S of the company, segment and market as a whole
P/S - Claritev Corp
Claritev Corp is likely an early-stage company in the medical or technology sector. With little or no revenue, this chart reflects purely speculative investor expectations. Any figure represents a bet on the future success of the technology or product, not a valuation of the current business.
P/S market segment - Medstrakh
Clarivate provides analytical information and data for scientific research, intellectual property protection, and the pharmaceutical industry. Revenue is generated from subscriptions to its databases and platforms. This chart for the information services sector helps assess the market's appreciation for Clarivate's unique data and analytical tools.
P/S of the market as a whole
Clarivate Analytics provides insights and data for scientific research, patent analytics, and pharmaceutical intelligence. The company's clients include universities, research centers, and corporations. This market revenue valuation chart helps understand how investors value a business based on providing critical data and a subscription model.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Claritev Corp
Clarivate is a global company providing analytical information and data for scientific research, intellectual property protection, and pharmaceuticals. This chart shows how investors estimate future revenue from its subscription services. It reflects the steady demand for high-quality information from universities, R&D departments, and law firms.
Future (projected) P/S of the market segment - Medstrakh
Clarivate, formerly part of Thomson Reuters, is a global provider of analytical information and data for scientific research, patent analytics, and pharmaceutical intelligence. The company's valuation reflects investors' confidence in the stability of its subscription business model and the importance of its data for innovation, as well as its strategy of growth through major acquisitions.
Future (projected) P/S of the market as a whole
Claritev Corp. works in the health insurance industry, analyzing data to optimize payments. The company operates at the intersection of IT and healthcare. This chart reflects general expectations, as Claritev works to improve the efficiency of one of the most expensive sectors of the economy.
Sales of the company, segment and market as a whole
Company sales Claritev Corp
Clarivate is a global information and analytics company. Its revenue, shown here, is generated by selling subscription products and services that provide access to databases on scientific research, patents, and pharmaceuticals. Its clients include universities, research centers, and corporations.
Sales of companies in the market segment - Medstrakh
Clariver (CTEV) is a company that provides technology solutions for health insurance, specifically for the Medicare program. Its platform helps insurers manage risks and optimize payments. This chart shows the total revenue of the health insurance sector, where Clariver plays a vital technology partner, improving the system's efficiency.
Overall market sales
Clarivate provides analytical information and data for scientific research, pharmaceuticals, and intellectual property protection. Demand for its services depends on the volume of R&D investment worldwide. This graph of overall economic activity correlates with corporate and government spending on science and innovation, which drives Clarivate's business.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Claritev Corp
Clarivate is a global information and analytics company providing data and analytics for scientific research, intellectual property protection, and pharmaceuticals. Its revenue depends on subscriptions to its databases and platforms. This chart shows analyst revenue expectations, reflecting the demand for high-quality information in academia and corporate communities.
Future (projected) sales of companies in the market segment - Medstrakh
Claritev Corp is a health insurance technology company. The forecast in this chart likely reflects expected revenue from their software solutions for insurance companies and healthcare providers. This is an analyst's view of the demand for technologies that help streamline processes in the complex healthcare sector.
Future (projected) sales of the market as a whole
Claritev is a health insurance company. Its business depends on the regulatory environment, competition, and the ability to effectively manage risk. This graph, reflecting the overall state of the economy, influences employment rates (the number of insured people) and the growth of medical costs, which are key factors for the insurance industry.
Marginality of the company, segment and market as a whole
Company marginality Claritev Corp
Claritev Corp, formerly known as MedAvail, developed automated pharmacy technology. Its financial indicators reflect the investment phase in developing and implementing this technology. The chart shows the financial health of a company attempting to disrupt the retail pharmacy market, where profitability depended on successful scaling and market acceptance of its innovations.
Market segment marginality - Medstrakh
Claritev Corp specializes in providing technology solutions and analytics to the healthcare industry, helping insurers and providers optimize their operations. This chart reflects the profitability of its service and software platform. Success depends on the ability to demonstrate the economic benefits of its products to clients.
Market marginality as a whole
Clarivate provides analytical information and data for scientific research and innovation. Its clients include universities, corporate R&D departments, and law firms. This total profitability chart reflects these organizations' ability to pay for premium data. Growing margins in the corporate sector allow companies to increase R&D budgets.
Employees in the company, segment and market as a whole
Number of employees in the company Claritev Corp
Claritev Corp is likely a small company or holding company, as information about it is limited. Such companies typically have a small staff focused on corporate management or a specific niche. The graph likely shows a stable and compact team, typical of a private or small operating entity.
Share of the company's employees Claritev Corp within the market segment - Medstrakh
Clarivate (the ticker symbol CTEV is believed to be incorrect) is a global leader in providing analytical information and data for science and business. Its greatest asset is its vast staff of experts, analysts, and data scientists. This chart illustrates the human scale required to collect, process, and analyze the vast amounts of information that underpin innovation.
Number of employees in the market segment - Medstrakh
Clarivate (ticker symbol CTEV is incorrect; correct: CLVT) is a global leader in providing analytical information for science and business. Employment trends in the health insurance sector are irrelevant. Clarivate prioritizes growth in R&D, as it creates demand for its databases, patents, and scientific publications, which help companies and universities accelerate innovation.
Number of employees in the market as a whole
Clarivate provides data and analytics to the life sciences industry. Its hiring of data scientists and analysts is tied to pharmaceutical companies' R&D budgets, which are influenced by broader economic conditions reflected in this data, making the company a key player in innovation.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Claritev Corp (CTEV)
Claritev (formerly Semler Scientific) develops technologies for chronic disease diagnostics. Its flagship product helps detect peripheral artery disease. This chart shows how the market perceives the potential of medical technologies that can reduce healthcare costs. The high cost per employee reflects the value of intellectual property.
Market capitalization per employee (in thousands of dollars) in the market segment - Medstrakh
Clarivate is an information analytics company that owns databases such as the Web of Science. Its primary assets are unique content and intellectual property. Its high capitalization per employee reflects the value of these intangible assets, which are monetized globally by a relatively small team.
Market capitalization per employee (in thousands of dollars) for the overall market
Clarivate provides services and data to accelerate innovation, including scientific publications and patent analytics. This chart reflects how the market values ββa business built on data and intellectual property. Value is created through unique databases and a team of analysts, not tangible assets, leading to high valuations per employee.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Claritev Corp (CTEV)
Claritev (CTEV) is an early-stage medical technology company. Details about its business are scarce, but like many R&D startups, this chart will likely show negative values. It reflects how much the company spends per employee to develop its product and bring it to market.
Profit per employee (in thousands of dollars) in the market segment - Medstrakh
Claritev Corp (CTEV) is a health insurance company that uses technology to manage Medicare Advantage programs. Efficiency in health insurance is the balance between premium collection, billing, and operating expenses (staff, IT). This metric reflects how profitably a company manages its insured portfolio.
Profit per employee (in thousands of dollars) for the market as a whole
Claritev Corp (CTEV) is a company providing technology solutions for health insurance, specifically for payment optimization and data management. It's an IT business in the healthcare industry. This chart helps evaluate the extent to which the company's software platforms automate complex processes in the labor-intensive healthcare industry, thereby increasing the value created by each employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee Claritev Corp (CTEV)
Clarivate (formerly part of Thomson Reuters) provides analytics and services in science and intellectual property. Its revenue per employee reflects the value of its unique databases and platforms, such as Web of Science. The chart shows how the company generates stable subscription revenue by serving universities, R&D departments, and law firms.
Sales per employee in the market segment - Medstrakh
Clarivate (CTEV) is a global company providing analytics and services in science, research, and intellectual property (IP). This chart shows the average revenue per employee in the segment. It helps assess how effectively Clarivate monetizes its databases and analytics tools using its staff.
Sales per employee for the market as a whole
Claritev Corp. is a provider of data and analytics for science and R&D. Clarivate manages databases such as Web of Science and holds patents. It is an information business. This metric demonstrates how effectively the company monetizes its unique datasets and analytical tools by selling subscriptions to thousands of universities and corporations through its staff.
Short shares by company, segment and market as a whole
Shares shorted by company Claritev Corp (CTEV)
Clarivate (CTEV), formerly part of Thomson Reuters, owns a suite of databases and analytical tools for science, research, and intellectual property (e.g., Web of Science). This chart shows "short" interest. The increase in this indicator may be related to concerns about the company's high debt load, difficulties integrating multiple acquisitions, or competition from new analytics platforms. (347)
Shares shorted by market segment - Medstrakh
Claritev (CTEV) works at the intersection of data and healthcare, helping insurers manage costs and evaluate treatment effectiveness. This chart reflects the overall sentiment in the sector. It reflects investor skepticism toward the "medinsurtech" sector, anticipating regulatory pressure or cuts to insurers' IT budgets.
Shares shorted by the overall market
Clarivate (CTEV), judging by its ticker symbol, likely stands for Clarivate Plc, a data analytics and intellectual property giant (Medstrakh may be an old name or a typo). They sell subscriptions to scientific and patent databases. This chart highlights skepticism about their business model, which relies on large amounts of debt (post-mergers) and subscriptions. Investors may question their ability to integrate assets and retain customers.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Claritev Corp (CTEV)
Clarivate (CTEV) is a major provider of data and analytics for scientific research, patents, and pharmaceuticals (e.g., Web of Science). Their business is subscription-based. This chart measures how the market perceives the stability of R&D budgets. It shows when the stock is overbought on growth expectations or oversold on fears of customer churn.
RSI 14 Market Segment - Medstrakh
Clarivate (CTEV - ticker likely refers to the former Clarivate, now CLVT) is an information analytics company. They own databases of scientific citations (Web of Science) and patents (Derwent). This chart shows the overall sentiment in the data and health insurance sectors. It helps assess how the market views providers of critical information.
RSI 14 for the overall market
Claritev (CTEV), a technology company in the health insurance industry. This chart reflects the IT budgets of the "old" economy. In a euphoric mood, insurers invest in digitalization. In a panic, they may "freeze" these projects, although the need for savings (promised by CTEV) may, on the contrary, stimulate demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CTEV (Claritev Corp)
Clarivate (formerly CTEV) is a global company providing analytics, data, and intellectual property solutions to academia, R&D, and pharmaceuticals. This chart shows the average analyst price target, reflecting their view on the sustainability of its subscription business model.
The difference between the consensus estimate and the actual stock price CTEV (Claritev Corp)
Claritev (CTEV) is a speculative medical technology company. They aim to develop and commercialize products that improve diagnostics or healthcare delivery. This chart reflects very early and hypothetical analyst expectations for their unproven technology and business plan.
Analyst consensus forecast for stock prices by market segment - Medstrakh
Claritev (CTEV) is a company providing analytics solutions for the healthcare sector, helping to optimize processes and improve outcomes. This chart shows the general expectations of analysts for the healthcare insurance sector. It reflects whether experts believe there will be a growth in demand for data analytics in the healthcare industry.
Analysts' consensus forecast for the overall market share price
Claritev Corp (CTEV) is a healthcare data and analytics company that helps insurers and hospitals optimize costs and improve treatment quality. This chart shows overall market sentiment. For Claritev, which operates at the intersection of IT and healthcare, the overall optimism is important because it reflects the sector's willingness to invest in high-end analytics platforms.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Claritev Corp
Claritev Corp (CTEV), which operates in the health insurance industry, likely provides technology solutions or services to streamline processes in this complex industry. This sector requires managing massive data flows, compliance, and costs. This chart is a summary indicator reflecting how the market views their business model, their ability to win contracts from insurers or providers, and their growth potential.
AKIMA Market Segment Index - Medstrakh
Claritev (CTEV) is a health insurance technology company that uses data and analytics to optimize insurance processes. This comprehensive index evaluates companies. The graph shows the sector average. This benchmark: how does this analytical model (CTEV) differentiate it from the average, traditional insurer?
The AKIM Index for the overall market
Claritev (presented as Medstrakh) is a company operating in the health insurance and services sector. Its activities involve health risk management. This chart, reflecting the market average, is a backdrop. It helps assess how this "protective" business, dependent on demographics and healthcare costs, compares to general macroeconomic fluctuations.